First Trust NYSE Arca Biotechnology Index Fund
109 hedge funds and large institutions have $281M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
2% less funds holding
Funds holding: 111 → 109 (-2)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
109
Holding in Top 10
3
Calls
$1.54M
Puts
$900K
Top Buyers
| 1 | +$24.4M | |
| 2 | +$4.35M | |
| 3 | +$2.26M | |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
+$1.99M |
| 5 |
LPL Financial
San Diego,
California
|
+$1.43M |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$2.8M | |
| 3 | -$2.56M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.04M |
| 5 |
Nomura Asset Management
Tokyo,
Japan
|
-$1.83M |